Opinion
Five years after the fatal Blue Bell listeria outbreak, the criminal case against the Texas ice cream company’s former chief executive has put it all back in the
Opinion
Blue Bell Creameries pleaded guilty on Monday to charges that they distributed adulterated ice cream products and will pay a criminal fine and forfeiture amount totaling $17.25 million.
The former chief executive of Blue Bell Creameries, Paul Kruse, may plead not guilty in an arraignment by video Tuesday, June 9, before U.S. Magistrate Judge Andrew W. Austin,
New documents filed in U.S. District Court for Western Texas in Austin say the former chief executive of Blue Bell Creameries remains free on a $50,000 unsecured bond.
Blue Bell’s former chief executive has waived physical appearance for his initial appearance in federal court on felony charges stemming from a 2015 Listeria outbreak.
The defendant, Paul Kruse,
After almost three weeks with almost no activity, the criminal case involving the United States v. Paul Kruse has inched forward.
U.S. Magistrate Judge Mark Lane filed an order
The U.S. Centers for Disease Control and Prevention’s (CDC) investigation into the Listeria outbreak linked to Blue Bell Creameries products is over, according to an update the agency
Blue Bell Creameries has signed a voluntary agreement with the Alabama Department of Public Health laying out a series of steps the company plans to take to control Listeria contamination
In response to a records request from a Dallas newspaper, the U.S. Food and Drug Administration (FDA) on Thursday posted four additional inspection reports of Blue Bell Creameries facilities
Blue Bell Creameries announced Friday that because of the “extended timeline” required for cleaning up its four manufacturing plants before resuming ice cream production, the company will cut hundreds of
The president and CEO of Blue Bell Creameries signed voluntary agreements on Thursday with the Texas Department of State Health Services (DSHS) and the Oklahoma Department of Agriculture, Food and
Inspection teams from the U.S. Food and Drug Administration (FDA) reported numerous problems after recent visits to three production facilities owned and operated by Blue Bell Creameries of Brenham,
